Emris Pharma
EMRIS Pharma is developing a first-in-class topical drug to prevent skin toxicities caused by EGFR inhibitor antibodies in cancer patients.
7-day free trial · no credit card
Verified contacts
3
available on Kipplo
LinkedIn employees
7
1 to 10 range
Open roles
—
no listings
Distinct roles
3
indexed titles
Tech stack
0
tools in use
Monthly traffic
—
organic / mo
Sign up free to see all 3 verified contacts at Emris Pharma
Free for 7 days · 50 credits · no card · only pay for verified records.
Decision-makers and verified team members
3 contacts with verified email or phone · masked until revealed.
- LA
Lyora Aharonov
Co-founder and CEO · Other
EmailPhone - SM
Sharon Merims
Chief Scientific Officer · Science
EmailPhone
Showing 2 of 3 verified contacts
Top roles at Emris Pharma
3 distinct titles indexed · top 3 shown.
- 1- ()
- 1chief scientific officer
- 1co-founder and ceo
Sign up to unlock all 3 contacts at Emris Pharma
Free for 7 days · 50 credits · no card · only pay for verified records.
Sign up to reveal 3 verified contacts at Emris Pharma
7-day trial · no credit card · cancel anytime · only pay for verified records.
Trusted by sales, marketing, and GTM engineering teams.